Elfatih Mohamed Malik Mohamed, MD

Director General
Planning and International Health Directorate
Federal Ministry of Health
Nile St, Khartoum, Sudan



• (Jan-March 2009), Global Health Leadership Program. 3 months training course in management and leadership at University of Washington, Seatle, USA
• (Sep-Oct 1997), WHO/EMRO regional course on planning malaria control programmes hosted by University of Tehran, Bandar Abass, Iran
• (Dec 1998), MD, Community Medicine, University of Khartoum
• (Dec 1995), First part, Clinical MD Community Medicine, University of Khartoum
• (Feb 1991), MBBS, Faculty of Medicine, University of Khartoum


• (July 2015), Director General, Planning and International Health Directorate, federal Ministry of Health, Sudan
• (May 2010-June 2015), Minister of Health, Gezira State, Sudan
• (Feb 2010-April 2010), WHO office, Sudan – Malaria control programme
• (April 2009), Assistant Under secretary of Health for PHC and Preventive Medicine, Federal MOH
• (April 2009), Community Medicine Council Rapporteur, Sudan Medical Specialization Board, Khartoum, Sudan
• (Jan 2008), Director, Communicable Diseases Control and Deputy of the Director General of the Preventive Medicine and PHC Directorate, Federal MOH
• (Jan 2007), Director General National Malaria and Vector-borne Diseases Control Programme, Federal Ministry of Health, Sudan
• (April 2005), Director General National Malaria and Leishmaniasis Control Programme and Focal person for integrating communicable disease control programs
• (April 2001), RBM National Coordinator and Deputy Director for National Malaria, Schistosomiasis and Leishmaniasis Control Programme
• (July 2000), Part-timer in Nillin University, Faculty of Medicine, teaching community medicine particularly communicable disease epidemiology
• (Oct 2000), Joint the Faculty of Medicine and Health Sciences, International University of Africa as a staff member
• (June 1998-June 2000), Joint Khartoum State Ministry of Health (KSMOH) as a Consultant for Preventive Medicine Directorate with special duties
• (Jun 1998-June 2000), Director Preventive Medicine (communicable diseases control) , KSMOH
• (March-Aug 1997), Acting Director General, MOH Khartoum State
• (March-Aug 1997), Executive Director of Health Insurance Programme, Khartoum State
• (Dec 1995-Feb 1997), Executive Director of Health Insurance Programme, Sinnar State
• (March -Sep 1995), Deputy Director of primary health care Directorate, Khartoum State
• (Feb. 1994-March 1995), Directorate General of Rural Hospital Directorate and Assistant Director General of KSMOH for planning and development
• (Dec 1992-Feb 1994), Deputy Director of Higher National Health Salvation Committee, Federal MOH and Executive Director of user fees programme
• (Sep 1991-Dec 1992), House officer, Khartoum North Teaching Hospital

Research Interest

His research interests include: Public Health.

Scientific Activities


• (November 2011) Member of the Malaria Policy Advisory Committee to the WHO which is an international committee with 12 members


1. Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group. The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data. Lancet Infect Dis. 2015; 15(6): 692-702. doi: 10.1016/S1473-3099(15)70024-1
2. Elmannan AA, Elmardi KA, Idris YA, Spector JM, Ali NA, Malik EM. Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance. BMC Pharmacol Toxicol. 2015; 16: 3. doi: 10.1186/s40360-015-0002-4
3. Mannan AA, Elmardi KA, Idris YA, Spector JM, Ali NA, Malik EM. Do frontline health care providers know enough about artemisinin-based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan. Malar J. 2015; 14(1): 131. doi: 10.1186/s12936-015-0652-0
4. Bilal JA, Gasim GI, Abdien MT, Elmardi KA, Malik EM, Adam I. Poor adherence to the malaria management protocol among health workers attending under-five year old febrile children at Omdurman hospital, Sudan. Malaria Journal. 2015, 14: 34. doi: 10.1186/s12936-015-0575-9
5. Mohamed KG, Hunskaar S, Abdelrahman SH, Malik EM. Scaling up family medicine training in Gezira, Sudan-a 2-year in-service master programme using modern information and communication technology: a survey study. Human Resources for Health. 2014; 12(1): 3. doi: 10.1186/1478-4491-12-3
6. Qader SAA, Malik FM, Babiker ARM. Factors affecting the distribution of health services Gezira State. Health and Development magazine. 2014; 2(1).
7. Al El sony, Chiang CY, Malik E, et al. Standard case management of Asthma in Sudan: A pilot project. Public Health action. 2013.
8. Dongola KJ, Zeid ANAA, Jack HU, Malik IAM. Gezira State program. Family Medicine: a success story. Journal of Health and Development. 2013; 1(4).
9. Malik FM. Preventive treatment and its impact in the fight against schistosomiasis: scientific review. Health and Development magazine. 2012; 2(1).
10. Malik FM. Local health system: scientific review. Health and Development magazine. 2012; 2(1).
11. Malik M, On the age of Babacar, Tayeb M, Isaac A. Geographical distribution and prevalence of schistosomiasis state Island. Health and Development magazine. 2012; 1(1).
12. Elsharif ME, Malik EM, Imam ME, Omran MO, Elsharif EG. Malaria incidence among kidney-transplanted recipients in an endemic malaria area, Sudan. Saudi J Kidney Dis Transpl. 2012; 23(5): 1099-1103. doi: 10.4103/1319-2442.100970
13. Hassan SE, Haggaz AE, Mohammed-Elhassan EB, Malik EM, Adam I. Fluorescence microscope (Cyscope(R)) for malaria diagnosis in pregnant women in Medani Hospital, Sudan. Diagn Pathol. 2011; 6(1): 88.
14. Elmardi KA, Noor AM, Githinji S, Abdelgadir TM, Malik EM, Snow RW. Self-reported fever, treatment actions and malaria infection prevalence in the northern states of Sudan. Malar J. 2011; 10: 128. doi: 10.1186/1475-2875-10-128
15. Wang K, Gimbel S, Malik E, Hassen S, Hagopian A. The experience of Chinese physicians in the national health diplomacy programme deployed to Sudan. Global Public Health. 2011. doi: 10.1080/17441692.2011.594450
16. Ahmed AM, Afifi AA, Malik EM, Adam I. Intestinal protozoa and intestinal helminthic infections among school children in Central Sudan. Ascian Pacific Journal of Tropical Medicine. 2010. doi: 10.1016/S1995-7645(10)60071-5
17. Menegon M, Talha AA, Severini C, et al. Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan. Am J Trop Med Hyg. 2010; 83(2): 250-257. doi: 10.4269/ajtmh.2010.09-0514
18. Adam I, Salah MT, Eltahir HG, Elhassan AH, Elmardi KA, Malik EM. Dihydroartemisinin-piperaquine versus artemether-lumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central Sudan. Ann Trop Med Parasitol. 2010; 104(4): 319-326. doi: 10.1179/136485910X12743554760144
19. Hassan Sel-D, Okoued SI, Mudathir MA, Malik EM. Testing the sensitivity and specificity of the fluorescence microscope (Cyscope) for malaria diagnosis. Malar J. 2010; 9: 88. doi:10.1186/1475-2875-9-88
20. Elamin SB, Awad AI, Eltayeb IB, et al. Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Sudan. Eur J Clin Pharmacol. 2010; 66(3): 231-237. doi: 10.1007/s00228-009-0750-4
21. El Sayed BB, Malcolm CA, Babiker A, et al. Ethical, legal and social aspects of the approach in Sudan. Malar J. 2009; 8(Suppl 2): S3. doi: 10.1186/1475-2875-8-S2-S3
22. Mustafa HS, Malik EM, Tuok HT, Mohamed AA, Julla AI, Bassili A. Malaria preventive measures, health care seeking behaviour and malaria burden in different epidemiological settings in Sudan. TMIH. 2009; 14 (12): 1488-1495. doi: 10.1111/j.1365-3156.2009.02394.x
23. Mannan AA, Malik EM, Ali KM. Antimalarial prescribing and dispensing practices in health centres of Khartoum state, 2003-04. East Mediterr Health J. 2009; 15(1): 122-128.
24. Elmardi KA, Malik EM, Abdelgadir T, et al. Feasibility and acceptability of home-based management of malaria strategy adapted to Sudans conditions using artemisinin-based combination therapy and rapid diagnostic test. Malar J. 2009; 8: 39. doi: 10.1186/1475-2875-8-39
25. Adam I, Elmardi KA, Malik EM. Predictors of antimalarial treatment failure in an area of unstable malaria transmission in eastern Sudan. Trans R Soc Trop Med Hyg. 2009; 103(1): 21-24. doi:10.1016/j.trstmh.2008.07.005
26. Adam I, Salih A, Khamis AH, Malik EM. Perceptions of the causes of malaria and of its complications, treatment and prevention among midwives and pregnant women of Eastern Sudan. Journal of Public Health. 2008. doi: 10.1007/s10389-007-0124-2
27. Hassan SEH, Malik EM, Okoued SI, Eltayeb EM. Retention and efficacy of long-lasting insecticide-treated nets distributed in eastern Sudan: A two-step community-based study. Malaria Journal. 2008; 7: 85. doi: 10.1186/1475-2875-7-85
28. Elkhalifa SM, Mustafa IO, Wais M, Malik EM. Malaria control in an urban area: a success story from Khartoum. East Mediterr Health J. 2008; 14(1).
29. Ibrahium AM, Kheir MM, Osman ME, et al. Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. Ann Trop Med Parasitol. 2007; 101(1): 15-21. doi: 10.1179/136485907X156924
30. Abdalla SI, Malik EM, Ali KM. The burden of malaria in Sudan: incidence, mortality and disability-adjusted-life-years. Malaria Journal. 2007; 6: 97. doi: 10.1186/1475-2875-6-97
31. Malik EM, Ali EM, Mohamed TA, et al. Efforts to Control Malaria in Sudan – case study of the National Malaria Control Programme, 2001-2005. Italian journal of tropical medicine. 2006; 11(3-4).
32. Malik EM, Mohamed TA, Elmardi KA, et al. From chloroquine to artemisinin-based combination therapy: The Sudanese experience. Malar J. 2006; 5: 65. doi: 10.1186/1475-2875-5-65
33. Malik EM, Hanafi K, Ali SH, Ahmed ES, Mohamed KA. Treatment-seeking behaviour for malaria in children under five years of age: implication for home management in rural areas with high seasonal transmission in Sudan. Malar J. 2006; 5: 60. doi: 10.1186/1475-2875-5-60
34. Maik EM, Eltayeb EM, Elmusaad YE, Elfadil T, Manoncout S, Shears P. Epidemc meningitis in Khartoum State, Sudan: An epidemilogical study of the 1999 epidemic. SJPH. 2006; 1(1): 13-20.
35. Mohamed AO, Eltaib EH, Ahmed OA, Elamin SB, Malik EM. The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan. Ann Trop Med Parasitol. 2006; 100(1): 5-10.
36. Elamin SB, Sidig GE, Elmardi KA, et al. The Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Falciparum Malaria in Children in an Area of High Transmission in Southern Sudan. SJPH. 2006; 1(3): 197-202.
37. Malik EM, Eltahir HG, Ahmed ES. Clinical and laboratory aspects of malaria among children with fever in a low transmission area of Sudan. East Mediterr Health J. 2005; 11(4): 753-761.
38. Malik EM, Nour SM, Hamid IK, Elmardi KA, Mohamed TA, Ahmed ES. From home to hospital: Beliefs and practices related to severe malaria in Sudan. Journal of Family & Community Medicine. 2005; 12: 85-90.

39. Elamin SB, Malik EM, Abdelgadir T, et al. Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan. Malar J. 2005; 4: 41. doi: 10.1186/1475-2875-4-41
40. Onwujekwe O, Malik el-F, Mustafa SH, Mnzavaa A. Do malaria preventive interventions reach the poor? Socioeconomic inequities in expenditure on and use of mosquito control tools in Sudan. Health Policy Plan. 2006; 21(1): 10-16. doi: 10.1093/heapol/czj004
41. Onwujekwe O, Malik el-FM, Mustafa SH, Mnzava A. Socio-economic inequity in demand for insecticide-treated nets, in-door residual house spraying, larviciding and fogging in Sudan. Malar J. 2005; 4(1): 62. doi: 10.1186/1475-2875-4-62
42. Salah MT, Mohammed MM, Himeidan YE, Malik EM, Elbashir MI, Adam I. A randomized comparison of sulphadoxine-pyrimethamine and combination of sulphadoxine pyrimethamine with chloroquine in the treatment of uncomplicated falciparum malaria in Eastern Sudan. Saudi Med J. 2005; 26(1): 147-148.
43. Adam I, A-Elbasit IE, Idris SM, Malik EM, Elbashir MI. A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. Ann Trop Med Parasitol. 2005; 99(5): 449-455.
44. Malik EM, Saeed OK. Malaria in Sudan: past, present and the future. Gazera Journal of Health Sciences. 2004, 1: 47-53.
45. Malik EM, Ahmed ES, Elkhalifa SM, Hussein MA, Sulieman AMN. Stratification of Khartoum Urban Area by the risk of malaria transmission. East Mediterr Health J. 2003; 9(4): 559-569.
46. Malik EM, Abdalla AH, Babiker AO, et al. Teachers-Centred Distribution of Praziquantel to Control Schistosomiasis in Gezira State, Sudan. Public Health Open J. 2016; 1(1): 8-11. doi: 10.17140/PHOJ-1-103